Meloxivet®

Oral solution.

Analgesic and anti-inflammatory.

Each mL of oral solution contains:
Meloxicam. ……………………………….. 1 mg
Excipients c.s.p… ……………………… 1 mL

MELOXIVET,® Meloxicam 1 mg/mL, Oral solution, is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.

Dogs.

Oral.

Administer an initial dose of 0.2 mL per kilogram of body weight on the first day of treatment, followed by a maintenance dose of 0.1 mL per kilogram of body weight every 24 hours. These doses are equivalent to administering an initial dose of the active substance of 0.2 mg/kg body weight on the first day of treatment, followed by a maintenance dose of 0.1 mg/kg body weight every 24 hours.
The duration of the treatment will depend on the condition to be treated. For acute pain, the duration of treatment can be extended for up to 15 days depending on the degree of pain and inflammation. For chronic pain, the duration of treatment can be extended by 21 to 28 days. Treatment, both acute and chronic, should be discontinued after 10 days if there is no apparent improvement or if vomiting or occult blood occurs in the stool.

The solution should be administered using the dosing syringe included in the package, depending on the weight of each animal. Administer mixed with a portion of food or directly into the dog’s mouth.

• Special care should be taken in dehydrated, hypovolemic and hypotensive animals as there is an increased potential risk of developing renal toxicity.
• Treatment should be discontinued if the expected clinical response is not observed.
• Keep out of reach of children and pets.

• Meloxicam is contraindicated in dogs with known hypersensitivity to Meloxicam, Piroxicam or other NSAIDs.
• Do not administer to dogs less than 6 months old or weighing less than 6 kilos.
• Meloxicam should not be used in dogs with ulceration or active gastrointestinal bleeding.
• Do not use in patients with liver, heart or kidney failure and bleeding disorders.
• Do not administer to pregnant or lactating females or breeding animals.

• Adverse effects reported in dogs treated with Meloxicam are similar to those seen with other NSAIDs and include gastrointestinal effects (vomiting, loss of appetite, loose stools, diarrhea, melena, gastrointestinal ulcerations, hematemesis), hepatic (elevated liver enzymes, jaundice), dermatological (pruritus, urticaria, dermatitis), renal (azotemia, elevated creatinine and blood urea, renal failure), central nervous system and behavioral (ataxia, personality disorders, convulsions, drowsiness, hyperactivity, depression, tremors and lethargy in puppies) and hematological disorders (alteration in clotting times, immune-mediated hemolytic anemia, immune-mediated thrombocytopenia).
• Unwanted effects usually occur after 7 days of treatment and in most cases are transient in nature and disappear once treatment is over. In the event of undesired effects and/or adverse reactions, treatment should be discontinued.

• Nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the effects of angiotensin-converting enzyme inhibitors (e.g., enalapril, Benazepril) on blood pressure.
• Meloxicam interacts with blood thinners such as Heparin or Warfarin and may increase the chance of bleeding.
• Its administration with corticosteroids or other NSAIDs may increase the risk of gastrointestinal toxicity (ulceration, bleeding, vomiting or diarrhea).
• NSAIDs may reduce the diuretic effects of furosemide.
• NSAIDs may increase the risk of nephrotoxicity when used in conjunction with nephrotoxic drugs or diuretics, such as furosemide and aminoglycosides.

• In case of contact with the skin, it is recommended to wash your hands with soap and plenty of water.
• In case of contact with eyes, wash with plenty of water for 15 minutes. If irritation develops and persists, consult a doctor.
• In case of accidental ingestion, do not induce vomiting. Wash your mouth with plenty of water. In case of developing gastric irritation, get medical help.

Any unused medicinal products or waste derived from them must be disposed of in an environmentally safe manner. Do not dispose of empty containers or containers with traces of the product in waterways. Do not dispose of empty containers or containers with leftover product with household waste. Contact the manufacturing laboratory to receive instructions regarding the correct disposal.

Store at a temperature between 15 and 30°C, away from light. Once opened, use the product within 30 days. Discard the unused product after that period of time.

Sale by prescription to the Veterinary Doctor.

VETERINARY USE
KEEP OUT OF REACH OF CHILDREN AND PETS

Chile: Reg. SAG No 2415
Peru: Reg. SENASA F.99.32.I.0130

Bottle with 60 mL

Laboratorio Drag Pharma Chile Invetec S.A.
Lautaro N° 300. Quilicura. Santiago. Chile.